Calaspargase Pegol-mknl
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Calaspargase Pegol-mknl, covering 2025-03-06 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) [Phase 2]